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Summary 
Motheaten viable (me*) mice are deficient in the cyto- 
solic protein tyrosine phosphatase, PTPlC, and ex- 
hibit severe B cell immunodeficiency and autoanti- 
body production. The role of PTPl C in B cell selection 
and function was analyzed by breeding immunogiobu- 
lin transgenes specific for a defined antigen, hen egg 
iysozyme, into me’ mice. Antigen triggered a greater 
and more rapid elevation of intracellular calcium in 
PTPlC-deficient B cells, indicating that this phospha- 
tase negatively regulates immunogiobuiin signaling. 
Elimination of self-reactive B cells carrying this signai- 
enhancing mutation was triggered during their devel- 
opment by binding a lower valency form of self-antigen 
than is normally required. These findings establish 
that activation of distinct repertoire-censoring mecha- 
nisms depends on quantitative differences in antigen 
receptor signaling, whose thresholds are determined 
by negative regulation through PTPlC. 
introduction 
Signaling by cell surface antigen receptors coordinates 
development and selection of B and T lymphocytes. Prior 
to infection, antigen receptor signaling in response to self- 
antigens underlies negative and positive selection steps 
that determine which clones mature to form the preim- 
mune repertoire of circulating lymphocytes and ensure 
self-tolerance. Following infection, binding of foreign anti- 
gens triggers clonal expansion of specific cells and produc- 
tion of antigen-specific antibody. Each of these selection 
steps depends on the existence of signaling thresholds. 
For example, negative selection must be limited to clones 
that bind self-antigens avidly to avoid eliminating too large 
a fraction of the preimmune repertoire, and clonal expan- 
sion in response to foreign antigens must be skewed to 
favor cells expressing antibodies with the highest possible 
affinity. Despite the broad significance of these limits for 
normal immunological function, little is known of the in- 
tracellular signaling molecules that help define such 
thresholds. 
Analyses of tolerance in B cell responses have provided 
a good model for analyzing requirements for threshold 
levels of receptor engagement, because antigen binding 
to immunoglobulin antigen receptors can be readily mea- 
sured (Dresser and Mitchison, 1966; Weigle, 1973; How- 
ard and Mitchison, 1975; Klaus et al., 1976; Metcalf et al., 
1979; Dintzis et al., 1963; Nossal, 1963). Two-cell autono- 
mous censoring mechanisms with distinct triggering 
thresholds have been defined using transgenic mice car- 
rying rearranged immunoglobulin heavy and light chain 
genes encoding self-antigen-binding receptors, in which 
large numbers of B cells carry the same receptor. The first 
mechanism halts maturation of self-reactive B cells at an 
immature short-lived stage of development in the bone 
marrow and eliminates them either through cell death 
(Hartley et al., 1993) or by replacing the receptor light chain 
with the product of another light chain gene rearrangement 
(Gay et al., 1993; Tiegs et al., 1993). Four highly multiva- 
lent self-antigens have so far been found to trigger this 
mechanism: H-2K histocompatibility molecules (Nemazee 
and Biirki, 1969), a membrane-bound form of hen egg 
lysozyme (mHEL) (Hartley et al., 1991), an erythrocyte cell 
surface antigen (Okamoto et al., 1992), and double- 
stranded DNA (Gay et al., 1993). Not all self-reactive B 
cells are censored in this way; immature B cells that bind 
a soluble form of lysozyme (sHEL; Goodnow et al., 1966) 
or single-stranded DNA(Erikson et al., 1991) are not devel- 
opmentally arrested and eliminated. Instead, these lower 
valency antigens render the B cells anergic and unable 
to multiply and produce antibody in the periphery. Anergy 
is brought about by a loss of cell surface antigen receptors 
of the immunoglobulin M (IgM) class, owing to selective 
retention of nascent receptors within the endoplasmic re- 
ticulum (Bell and Goodnow, 1994), and by desensitization 
of the remaining IgM and the IgD receptors, such that 
they are poorly able to activate tyrosine kinases or trigger 
elevation of intracellular calcium (Cooke et al., 1994). An- 
ergy also exhibits a threshold requirement, since self- 
reactive B cells that bind sHEL at too low a concentration 
or with insufficient affinity are neither inactivated nor elimi- 
nated (Goodnow et al., 1969; Adelstein et al., 1991). Simi- 
larly binding of H-2K molecules in soluble form (Nemazee 
et al., 1991) or of self-lgG2a with low affinity (Shlomchik 
et al., 1993) are also insufficient to trigger either B cell- 
censoring mechanism. Taken togetherwith earlier studies 
of B cell tolerance (see references above), these findings 
favor the hypothesis that self-antigen valency and concen- 
tration, together with receptor affinity, determine which 
censoring mechanism is triggered in immature B cells by 
affecting the strength of intracellular signaling (reviewed 
by Nemazee et al., 1991; Goodnow, 1992). 
A great deal has been learned in recent years about the 
molecules that play positive roles in transmitting intracellu- 
lar signals from B and T cell antigen receptors. The immu- 
noglobulin antigen receptors on B cells signal through as- 
sociated molecules CD79a (mbl) and CD795 (829) which 
couple to src family tyrosine kinases and become tyrosine 
phosphorylated following antigen receptor cross-linking 
(Reth, 1992; Cambier et al., 1994; Gold and DeFranco, 
1994). The phosphorylated receptors in turn recruit the 
cytosolic tyrosine kinase, syk, and activate downstream 
signaling cascades, including mobilization of intracellular 
calcium and activation of p21 ras. While each of these sig- 
naling events is transient, only a small number of mole- 
cules that oppose and curtail them have so far been de- 
fined. The actions of these down-regulatory molecules are 
likely to be critical in defining signaling thresholds in lym- 
phocytes. 
A promising approach for identifying molecules that con- 
trol B lymphocyte development and selection is offered 
by inbred mouse strains carrying heritable mutations that 
lead either to B cell immune deficiency or to the breakdown 
of self-tolerance and production of autoantibodies. The 
allelic spontaneous moues mutants, motheaten (me) (Shultz 
and Green, 1976) and motheaten viable (me”) (Shultz et 
al., 1984) represent extreme examples of mutations that 
have both effects, since they lack mature conventional 6 
cells and make poor antibody responses following immuni- 
zation, yet develop autoantibodies by 4 weeks of age 
(Shultz and Green, 1976; Sidman et al., 1978a; Davidson 
et al., 1979; Painter et al., 1988). The mutations also result 
in elevated macrophage and granulocyte activity, excess 
erythropoiesis, and reduced T and NK cell activity (Shultz, 
1988), complicating analyses of B lymphocyte selection 
and function in the mice. Both motheaten alleles have 
recently been shown (Shultz et al., 1993; Tsui et al., 1993) 
to disrupt the gene encoding a cytosolic protein tyrosine 
phosphatase, PTPlC, (also termed SHP, HCP, and SH- 
PTPl) that is widely expressed in hemopoietic cells (Shen 
et al., 1991; Matthews et al., 1992; Plutzky et al., 1992; Yi 
et al., 1992). PTPl C is a member of the family of PTPases 
containing two amino-terminal src homology 2 domains, 
a conserved phosphatase domain, and a regulatory car- 
boxy-terminal domain (Shen et al., 1991; Matthews et al., 
1992; Plutzky et al., 1992; Yi et al., 1992; Pei et al., 1993; 
Townley et al., 1993). The me allele ablates PTPl C activ- 
ity, while the me” allele disrupts a splice site within the 
PTPase domain, leading to aberrantly sized products and 
an enzyme activity 100/b-20% of wild type (Kozlowski et 
al., 1993; Shultz et al., 1993; Tsui et al., 1993). 
To examine the role of PTPlC in negative selection of 
self-reactive B cells, we have introduced the me” mutation 
into a lysozymelimmunoglobulin-transgenic model used 
previously to define thresholds for eliminating or inactivat- 
ing self-reactive B cells. B cells deficient in PTPlC show 
an exaggerated elevation of intracellular calcium in re- 
sponse to HEL antigen binding, and a reduced threshold 
for triggering arrested development and elimination. 
These findings strongly argue that PTPlC is a negative 
regulator of immunoglobulin antigen receptor signaling 
that sets signaling thresholds for negative selection. 
Results 
Immunoglobulln-Transgenic me” Mice Exhibit 
the Motheaten Phenotype 
To study how PTPlC deficiency affects B cell develop- 
ment and negative selection, C57BU6-transgenic mice 
carrying immunoglobulin heavy and light chain transgenes 
encoding lgMB and IgD” specific for lysozyme (MD mice) 
were crossed with C57BU6 me”/+ carriers and me” homo- 
zygotes were derived. Immunoglobulin-transgenic me” ho- 
mozygotes developed bald patches on the skin within the 
first week of life and had a lifespan of less than 9 weeks, 
equivalent to me” littermates lacking the immunoglobulin 
transgenes. B lymphopoiesis in the bone marrow was low 
as observed in nontransgenic me” mice (Figure 1; Greiner 
et al., 1986). In the spleen, the average number of B cells 
in 4- to d-week-old immunoglobulin-transgenic me” mice 
(5 x lo6 cells or l%-5% of spleen cells; Figure lC), was 
approximately lo-fold less than in wild-type (+I+ MD) 
immunoglobulin-transgenic mice (Figure 1 C), although 
the majority of B cells continued to express transgene- 
encoded receptors and bind lysozyme avidly. A similar 
reduction in B cell number occurred in nontransgenic me” 
spleens (Figure 1 B). 
Maturation of B cells was determined using three devel- 
opmentally regulated cell surface markers: IgM, IgD, and 
complement receptors 1 and 2 (CRl/CR2; Figure 1A). The 
majority of mutant MD-transgenic B cells expressed high 
levels of IgD (Figure 1C) and low to moderate amounts of 
CFWCRP (Figure lD), indicating that they were mature 
follicular-type B cells. Since splenic B cells from non- 
transgenic me” homozygotes expressed little or no IgD 
(Figure 1 B), the transgenic receptor appeared to restore 
B cell maturation. Interestingly, many splenic B cells in 
me” MD-transgenic mice expressed 1 O-fold less cell sur- 
face IgM than (+I+) MD B cells, despite having normal 
levels of IgD (Figure 1 C). Low IgM expression and medium 
CRl/CRP expression is characteristic of anergic B cells 
chronically exposed to sHEL autoantigen in MDlsHEL 
double-transgenic mice (Bell and Goodnow, 1994). Unlike 
cells rendered tolerant by antigen, however, B cells in me” 
MD-transgenic spleens were larger than those in wild-type 
animals and thus appeared to be activated (Figure 1D). 
Moreover, serum anti-HEL lgMalevels were approximately 
IOO-fold higher in me” MD animals (12 f 9 mglml) than in 
(+/+) MD mice (Goodnow et al., 1988). Collectively, these 
findings indicated that B cell development and function 
was altered in me” immunoglobulin-transgenic mice, but 
it was impossible to determine whether these changes 
resulted from PTPlC deficiency in the B cells themselves 
or in other cells around them. In particular, excessive activ- 
ity of the myeloid cells in me” mice can suppress B lympho- 
poiesis in trans (Medlock et al., 1987; Hayashi et al., 1988). 
Chimeric Animals Defining Intrinsic Defects in 
PTPlCDeficient B Cells 
To distinguish c/s effects of PTPlC deficiency within B 
cells from trans effects due to abnormalities in other hemo- 
poietic lineages, irradiation bone marrow chimeras were 
generated following the strategy outlined in Figure 2A. 
This approach had two chief advantages: me” bone mar- 
row could be diluted with (+/+) bone marrow, reducing 
trans effects from overproduced mutant myeloid cells, and 
bone marrow from (+/+) anti-lysozyme immunoglobulin- 
transgenic mice could be included to provide (+/+) B cells 
as an internal control for trans activity. To distinguish inter- 
nal control B cells and their secreted immunoglobulin prod- 
uct from the me” B cells, the (+I+) bone marrow inoculum 
was obtained from DD mice carrying an immunoglobulin 
transgene with an internal deletion spanning the Ctr locus 
(Brink et al., 1992). B cells from DD-transgenic bone mar- 
row lack lgMB but express lysozyme-binding cell surface 
IgD” and secreted IgD” instead. DD B cells are otherwise 
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Figure 3. Splenic Architecture and B Cell Phenotype in Chimeric Mice 
(A-C) Top: two-color immunohistochemical staining of spleen sections from mixed bone marrow chimeras of the type in Figure 2. IgfW cells are 
selectively revealed by brown staining, while all B cells are stained for 8220 in red. Bottom: two-color flow cytometry of splenocytes from the 
indicated chimeras stained for HEL binding and Ly5’. Percentages of spleen cells present within windows are shown. 
(D) Overlaid histograms of Ly5” (+/+) MD B cells (thin solid lines), and Ly5” me” MD B cells (thick lines) in nontransgenic recipients reconstituted 
with 20% me” MD bone marrow and 80% (+I+) DD-Ly5’ bone marrow. Shown are forward laser light scatter (1) as an indicator of cell size and 
immunofluorescent staining for HEL-binding immunoglobulin (2); transgene-encoded lgD’(3); IgW(4); and class II molecules (5). For comparison, 
in panels 2-5 the broken line shows staining of (+I+) MD cells in a sHEL-transgenic recipient (+/+MD/sHEL). Equivalent results were obtained 
from 10 chimeric mice. 
marrow, production of both me” (LySa-) and (+I+) (LyL!P+) of nucleated nonlymphoid cells with only small and poorly 
B ceils in the bone marrow was low (Figures 28 and 2C), defined lymphoid white pulp cords (Figure 3A), again rep- 
confirming that B lymphopoiesis is inhibited in trans (Med- resenting a dominant trans effect of the me” mutation on 
lock et al., 1987; Hayashi et al., 1988). Spleen architecture lymphoid development. By contrast, when only 20% of the 
in these chimeras was dominated by red pulp consisting bone marrow stem cells were me” derived, HEL-binding B 
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Figure 1. Low Number and Altered Phenotype of B Cells Produced 
in Homozygous me” lmmunoglobulin Transgenic Mice 
(A) Stages of conventional B cell differentiation and cell surface mark- 
ers used to distinguish them. The immediate progenitor of marginal 
zone type B cells is not firmly established and alternative routes to 
that shown are possible. 
(B) B cell development in (+/+) and homozygous me” nontransgenic 
mice. Two-color flow cytometry of cells from bone marrow (left) or 
spleen (right) stained for IgW and IgDb. Percentages of cells are shown 
in the windows. 
(C) B cell development in 4.5week-old (+I+) and homczygous me” MD 
immunoglobulin-transgenic mice. Analysis was identical to(B) except 
staining was for the transgene-encoded a allotypes of IgM and IgD. 
Figure 2. Identification of Intrinsic Defects in PTPIC-Deficient BCells 
through Generation of Mixed me?(+/+) Irradiated Bone Marrow Chi- 
meras 
(A) Experimental design to dilute out and internally control for Vans 
effects mediated by me” myeloid and other non-B cells, by reamsMut- 
ing irradiated recipients with mixtures of me” and (+I+) bone marrow 
from immunoglobulin-transgenic mice that were marked with distinct 
immunoglobulin isotypes and an allelic Ly5’ surface marker. 
(B) Two-color flow cytometry of bone marrow cells from irradiated non- 
transgenic mice reconstituted 6 weeks earlier with the indicated bone 
marrow mixtures. The percentages of bone marrow cells that are HEL- 
binding Ly5’- (me? B cells or HEL-binding Ly5” (+I+) B cells are shown 
in the respective windows. 
(C) Numbers of HEL-binding cells isolated from one tibia and femur, 
enumerated as in (B). Dots represent the number from separate chime- 
ric animals and bars indicate means. 
functionally indistinguishable from MD 6 cells. Thus, in 
mixed chimeras, secreted IgM” would be strictly of me” B 
cell origin, whereas secreted IgD” would be largely derived 
from the (+/+) DD-transgenic cells, as MD cells secrete 
little IgD’ (Brink et al,, 1992). As an additional marker to 
distinguish me” and (+/+) B cells and to measure overall 
hemopoietic chimerism, DD donors carrying the congenic 
Ly5” allele of CD45 were used (Figure 2A). 
In chimeras reconstituted with 50% me” and 50% (+/+) 
(D) Histograms of complement receptor expression and forward laser 
light scatter of (+/+) and homozygous me’ MD immunoglobulin- 
transgeniccells, gatedon HEL-binding Bcells. Background(neg)CRl/ 
CR2 staining was determined from the level of staining of non-B cells. 
The lo-med and high CFWCR2 peaks clearly evident in wild-type B 
cells correspond to mature follicular and marginal zone stages shown 
in (A). Forward laser light scatter is shown as an indicator of cell size. 
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Figure 4. Enhanced Elevation of Intracellular Free Calcium Following Antigen Binding in PTPlC-Deficient B Cells 
Flow cytometry of Indo-l-loaded cells was used to monitor intracellular calcium levels as a function of time in freshly isolated splenic (A-D) or 
bone marrow (E-H) B cells before and after addition of HEL antigen (arrows) at the indicated final concentrations. All measurements are gated 
on B220+ cells. Left panels in (A)-(G) show tracings gated on Ly5”- me” MD B cells in 20% me” MD:80% (+/+) DD chimeras, and right panels 
show tracings gated identically on Ly? (+I+) MD cells in 20% (+I+) MD:80% (+I+) DD chimeras. In (E)-(H), calcium measurements from immature 
B cells were selectively gated as 82200, CRVCFW. In (H), the left and right panels represent tracings from Ly5O- me” MD cells and from Ly5” 
(+I+) MD cells within the same 20% me” MD:80% (+I+) MD chimera. Equivalent results were obtained from 8 chimeric animals of eech type. 
cells of both the me” and internal control type were gener- 
ated in the bone marrow in numbers comparable to those 
in parallel chimeras in which 20% (+I+) MD bone marrow 
was used (Figures 28 and 2C). Similarly, dilution of me” 
stem cells to 20% restored normal splenic architecture, 
resulting in well-defined lymphoid white pulp cords con- 
taining typical follicular structures (Figures 38 and 3C). In 
spleens from 20% chimeras, the number of internal control 
DD cells was equivalent in chimeras having 20% me” MD 
or 20% (+I+) MD marrow (Figures 38 and 3C). However, 
despite normal production of immature HEL-binding B 
cells in the bone marrow, there were approximately 1 O-fold 
fewer mature splenic B cells derived from the me” stem 
cells than were derived from (+I+) controls (Figure 38). 
This may reflect failure to reach a long-lived state in the 
periphery. 
increase in class II expression was also detected on 
me” B cells (Figure 3D), whereas other activation markers, 
including 87.2 and CD44, were expressed at low levels 
equivalent to (+I+) B cells (data not shown). 
Exaggerated Intracellular Calcium Response 
in PTPlCDeficlent B Cells 
The unusual phenotype of me” B cells closely resembled 
that of anergic (+I+) B cells that are chronically exposed 
to antigen in sHEL-transgenic mice (e.g., broken lines in 
Figure 3D), raising the possibility that comparable chronic 
signaling occurred in me” B cells in the absence of HEL 
antigen. Since anergic B cells also show a profound desen- 
sitization of slg signaling (Cooke et al., 1994) antigen- 
induced elevation of intracellular calcium was measured 
in the me” B cells. 
Me” MD-transgenic Bcells in the spleen of 20% chimeric Indo-l-loaded B cells from 20% me” chimeric animals 
mice were small, equivalent in size to (+I+) MD B cells and controls were stimulated with soluble HEL and the 
(Figure 3D), and the majority expressed high surface IgD rise in intracellular calcium measured by flow cytometry. 
(Figure 3D) and medium levels of CRllCRP (data not Surprisingly, exposure of me” MD-transgenic spleen cells 
shown; see Figure 6) indicating that they were mature. to HEL at 100-1000 nglml induced a greater and more 
The number of HEL-binding receptors expressed on the sustained rise in intracellular calcium than occurred in 
mutant splenic B cells was lower than on the wild-type (+I+) cells present in control chimeras (Figures 4A-4D). 
controls (Figure 3D), owing to selective down-regulation When the cells were exposed to decreasing concentra- 
of IgM (Figure 3D). The distinct phenotype (IgM”‘IgD’” tions of HEL, a similar titration of responsiveness was ob- 
CD21msd) of me” B cells was therefore due to effects of served, such that at 1 nglml the response of both wild-type 
PTPlC deficiency within the B cells themselves. A small and mutant cells was only slightly above background (Fig- 
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ure 4D). However, at low antigen concentrations when 
calcium elevation was not measurably greater in me” than 
in (+I+) B cells, the Ca2+ response nevertheless occurred 
earlier in mutant cells, taking 1.5 min to peak after addition 
of 1 nglml HEL compared with 2.5 min with (+/+) B cells 
(Figure 4D). 
The exaggerated calcium response to antigen in me” B 
cells reflected either a direct effect of PTPlC deficiency 
or one of several possible indirect effects. The elevated 
calcium flux could not be attributed to greater HEL binding 
by the me” B cells, since fewer receptors were present 
than on (+/+) controls (see Figure 3). However, the lower 
expression of CRlICR2 on the mutant cells and their fail- 
ure to accumulate in the periphery raised the possibility 
that the difference in calcium flux might reflect a difference 
in the maturation state of me” and (+/+) B cells. To exclude 
this variable, signaling in immature (B22OWRl/CR2-) 
bone marrow B cells was examined, since the cell surface 
phenotype of immature me” and (+I+) B cells was identical 
(Figure 5; data not shown). As with splenic B cells, imma- 
ture me” B cells showed a markedly greater rise in intracel- 
lular calcium than wild-type cells in control chimeras (Fig- 
ures 4E-4G). A third indirect effect that might have 
accounted for the exaggerated response of me” B cells 
was the possibility of residual trans effects, owing to my- 
eloid hyperactivity, for example. The DD cells could not 
be used as an internal control for trans effects in this case, 
Figure 5. PTPlC-Deficient B Cells that Bind 
Self-Antigen Have Exaggerated Receptor 
Modulation and a Reduced Threshold for Ar- 
rested Development and Elimination in the 
Bone Marrow 
(A) Numbers of immature 8220” HEL-binding 
B cells in chimeric animals lacking HEL antigen 
or expressing sHEL or mHEL. Ly5’- me” or (+/+) 
MD B cells and LyV (+/+) DD internal control 
B cells were enumerated as in Figure 2. Mean 
number of cells per one tibia plus one femur, 
standard deviation, and number of animals in 
each group are shown. 
(8) Modulation of HEL-binding receptors in the 
presence of HEL autoantigen. Histograms 
show HEL-binding receptors present on Ly5* 
or Ly5’ B22(y” immature B cells in the indi- 
cated mixed bone marrow chimeras. In the left 
panels, note the greater reduction in HEL- 
binding receptors on me” B cells exposed to 
sHEL (Ly5’ cells, solid lines) compared with 
internal control (+/+) B cells in the same mouse 
(Ly5” cells, broken line), or compared with 
Ly5”’ and Ly5” B cells in control chimeras 
(right panels). The thin line (control) in upper 
panels only shows staining of nontransgenic B 
cells for comparison. 
(C) Effect of HEL autoantigen on maturation 
to a CRl/CRP+ state. Histograms of CRllCR2 
expression by Ly5* and Ly5’ 8220” immature 
B cells in chimeras as in (B). The percentage 
of Ly5.- and Ly5*+ immature B cells that are 
CRl/CR2+ is shown in each panel. Note that 
sHEL selectively prevents maturation of me” B 
cells (solid lines, left center panel). The HEL- 
binding and CRlKR2 histograms shown are 
representative of 7-8 mice of each type. 
as immature B cells in MD mice express exclusively IgM 
(see Figure 1A). Thus, a separate set of chimeras was 
established incorporating 20% me” MD marrow and 80% 
(+I+) MD LYLE+ marrow. Immature (+I+) MD cells devel- 
oping in a 20% me” chimera continued to respond nor- 
mally, despite exaggerated responses in me” B cells from 
the same tissue (see Figure 4H), ruling out possible trans 
effects as an explanation for the elevated calcium mobili- 
zation. 
PTPlC-Deficient B Cells Have a Reduced 
Self-Antigen Threshold for Arrested 
Development and Deletion 
in the Bone Marrow 
The findings above established that me” B cells in the 
absence of HEL antigen displayed several unique features 
of cells that were chronically exposed to antigen; in partic- 
ular, reduced IgM expression on mature IgD+ cells, yet 
showed the opposite phenotype at the level of immuno- 
globulin signaling, namely an exaggerated intracellular 
calcium response. To examine the fate of me” B cells when 
they were exposed to either the weak antigen, sHEL, or 
the stronger antigen, mHEL, during in vivo development, 
the same strategy of mixed bone marrow chimeras was 
employed, but recipient animals expressing either sHEL 
or mHEL were used. In the resulting chimeras, the number 
of immature bone marrow B cells from the DD internal 
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control inoculum was similar whether 20% me” or 20% tion marker CRlICR2 also indicated that the response of 
(+I+) MD cells were included in the inoculum (Figure 5A). me” B cells to sHEL resembled that of (+/+) B cells to the 
The number of (+I+) MD B cells was slightly increased in stronger antigen mHEL. In the absence of antigen, 40%- 
mHEL recipients, owing to arrested development following 50% of the bone marrow me” or (+/+) B cells had matured 
encounter with membrane-bound antigen prior to elimina- to a stage expressing CFWCRP at low to medium levels 
tion (Hartley et al., 1993). By contrast, while immature (Figure 5C, top). In sHEL recipients, however, maturation 
me”B cells were in the normal range in the bone marrow in continued in (+I+) B cells (Figure 5C, middle: broken lines) 
nontransgenic recipients (Figure 5A), their numbers were but CRllCRP expression was completely blocked on 
reduced 2-fold in sHEL recipients and 5fold in mHEL re- me” B cells (Figure 5C, left middle: solid lines), equivalent 
cipients. The number of B220+ HEL- pre-B cells was equiv- to that which occurred in (+I+) cells in mHEL recipients 
alent in the three types of recipient (data not shown), con- (Figure 5C, bottom). Since (+/+) MD cells developing in 
firming that the decrease in immature me” B cell number 20% me”sHEL chimeras continued to reach a CRl/CR2+ 
occurred after cell surface IgM expression and encounter stage, the arrested development of me” B cells in response 
with autoantigen. to sHEL reflected PTPlC deficiency within the B cells. 
An exaggerated response to autoantigen in me” B cells 
was clearly evident from itseffect on expression of IgM and 
CRlICR2. In the absence of HEL antigen, IgM receptor 
expression on immature me” B cells (Figure 58, left: solid 
lines) was similar to that on (+/+) B cells (Figure 58, left: 
broken lines, and both histograms in right). In the presence 
of sHEL, however, antigen receptors were modulated only 
4- to 5-fold on (+/+) cells but were reduced 15- to 20-fold 
on me” B cells (Figure 58, middle), the latter being compa- 
rable to that induced by mHEL in (+/+) cells. In mHEL- 
bearing recipients, the developing me” B cells exhibited 
an even greater reduction of antigen receptors (Figure 58, 
bottom). Equivalent gating of (+I+) cells in control chime- 
ras (Figure 58, right) confirmed that the exaggerated re- 
ceptor modulation in response to autoantigen was a cis 
effect of the me” mutation. Staining for the B cell matura- 
The effect of autoantigen on me” B cell development 
was further examined by measuring B cell numbers and 
maturity in the spleen. Strikingly, few me” B cells reached 
the spleen in mice expressing soluble HEL (Figure 6A, 
solid bars) and thesmall number detected failed to express 
CRlICR2, indicating that they were still immature (Figure 
6B, bottom: solid lines). In addition, few or no cells were 
detectable in lymph nodes or peritoneum, while the num- 
bers and phenotype of cells in the blood paralleled those 
in the spleen (data not shown). This was again very similar 
to the fate of (+/+) B cells exposed to the stronger antigen 
mHEL (Figure 6A, open bars; Hartley et al., 1993) and 
contrasted with the fate of (+/+) cells exposed to soluble 
HEL, where the cells matured and reached the periphery 
in numbers within 4-fold of normal. The internal control 
DD cells showed only the characteristic P-fold reduction 
Figure 6. Elimination of PTPlC-Deficient B 
Cells by sHEL Autoantigen: Effect on Periph- 
eral B Cell Numbers and Antibody Production 
(A) Numbers of Ly5’ or Ly5” HEL-binding 
B220+ cells in the spleen. Chimeras were re- 
constituted with the indicated bone marrow 
mixtures and either lacked HEL or expressed 
sHEL or mHEL as in Figure 5. Mean number 
of cells per spleen, standard deviation, and 
number(n)ofanimalsineachgroupareshown. 
(B) Histograms of CRllCRP expression by 
8220’ Ly5’ me” MD B cells (solid line) and 
(+I+) MD B cells (dashed line) in the chimeras 
shown in (A). 
(C) Tolerance to HEL as assessed by serum 
anti-HEL lgM*(top) and anti-HEL IgD’(bottom) 
in the chimeras shown in (A). Mean, standard 
deviations and number (n) of animals in each 
group are shown. 
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in B cell number in sHEL recipients and developed compa- 
rably in chimeras with 20% me” or (+/+) marrow cells (Fig- 
ure 6A, stippled bars). Even fewer me” 6 cells reached 
the spleen in mHEL recipients, indicating more complete 
deletion than in (+/+) B cells exposed to mHEL. 
At the level of secreted antibody, induction of self- 
tolerance in me” B cells was indistinguishable from (+I+) 
B cells. Serum anti-HEL IgM” concentrations were re- 
duced to below the limit of detection (50 rig/ml) in sHEL 
or mHEL recipients of bone marrow containing 20%1 me” 
MD or 20% (+/+) MD stem cells (Figure 6C). The number 
of anti-HEL lgMB antibody-secreting cells per spleen was 
similarly reduced (data not shown). Serum anti-HEL lgDB 
levels were also reduced equivalently in 20% me” and 
20% (+/+) chimeras expressing soluble and membrane 
HEL (Figure 6C), indicating that any trans effects that 
might affect self-tolerance were sufficiently minimized 
when only 20% of the bone marrow carried the PTPlC 
mutation. 
PTPlC Deficiency Favors Formation of B-l-Type 
Peritoneal B Cells 
A characteristic of nontransgenicme” mice is the presence 
of a distinct population of large B-l cells, which contrasts 
with the deficiency of conventional small follicular B cells 
(Sidman et al., 1966). In (+/+) immunoglobulin-transgenic 
mice, expression of the anti-HEL receptor prevents B cells 
from adopting a B-l phenotype, as no HEL-binding cells 
with this phenotype are detectable in the peritoneum, nor- 
mally the richest source of B-l cells (Kantor and Herzen- 
berg, 1993). When B-l-type cells are detected (predomi- 
nantly in older immunoglobulin-transgenic animals), the 
cells have all lost expression of the immunoglobulin 
transgenes and express endogenous lgMb (data not 
shown). In me” immunoglobulin-transgenic mice, by con- 
trast, HEL-binding B cells expressing only the transgenic 
receptor were entirely of B-l type in the peritoneum (data 
not shown). This phenotypic change also occurred in the 
peritoneal cavity of 20% me” chimeric animals (Figure 7). 
Thus, while (+/+) HEL-binding MD cells in this site were 
small IgD+, B220hi, and Mac-l-, typical of conventional 
recirculating B cells, the me” B cells in the same location 
were large B22O’O, IgD’+, and Mac-l + (Figures 7A and 7B), 
this phenotype being characteristic of B-l cells (Kantor 
and Herzenberg, 1993). Deficiency of PTPlC within B 
cells, therefore, facilitated the development of an activated 
B-l phenotype, despite expression of anti-HEL receptor 
transgenes that normally prevent this fate. 
Discussion 
Establishing thresholds for lymphocyte antigen receptor 
signaling and selection is central to the normal function of 
the immune system. This study provides genetic evidence 
that PTPlC is an important negative regulator of antigen 
receptor signaling and selection in B lymphocytes. Thus, 
antigen elicited a larger and more rapid elevation of intra- 
cellular calcium in PTPlC-deficient B cells than in (+/+) 
B cells, and this was a cis effect of the mutation, as (+/+) 
B cells present in the same animal did not show elevated 
Figure 7. B-1 Phenotype of PTPlC-Deficient MD Transgenic B Cells 
in the Peritoneum 
(A) Histograms of forward laser scatter, 8220 expression, and Mac-l 
expression by peritoneal Ly5’- (me” MD) and Ly5’+ (+/+ MD) B cells 
in a single chimera. 
(B) Expression of transgene-encoded IgM’ and IgD’ by Ly5’- me” MD 
and Ly5’+ (+/+) MD cells in the same chimera. The B220w IgDw- pheno- 
type and large size of me” peritoneal B cells is representative of 10 
mice and Mac-l expression is representative of 6 mice. 
responsiveness. Self-reactive B cells with exaggerated 
signaling due to PTPlC deficiency were deleted in the 
bone marrow by a less multivalent form of antigen than 
is normally required, indicating that negative regulation by 
PTPlC plays a key role in setting thresholds for negative 
selection. 
Understanding the overproduction of autoantibodies 
and defects in B cell development in motheaten mice has 
been complicated by the multilineage phenotype of this 
strain (Green and Shultz, 1975; Shultz and Green, 1976; 
Sidman et al., 1976a, 1978b; Davidson et al., 1979; Shultz 
et al., 1984). Several dominant aspects of the motheaten 
phenotype have been attributed to macrophages or mac- 
rophage-like cells. The number of these cells is elevated 
in lymphoid tissues and bone marrow, their production is 
augmented in spleen and bone marrow cell cultures, and 
they inhibit B cell responses and lymphopoiesis in vitro 
(Green and Shultz, 1975; McCoyet al., 1982,1983; Shultz 
et al., 1984; Medlock et al., 1987; Hayashi et al., 1988). 
Moreover, treatment with antibody to the predominantly 
macrophage-specific antigen, CD1 1 b (Mac-l), blocks ap- 
pearance of skin and lung lesions in me” bone marrow 
chimeras and restores production of T lymphocytes and 
NK cells (Koo et al., 1993). B cell production in vivo in the 
bone marrow was clearly inhibited by some other hemato- 
poietic cell type in trans in the studies here, since lympho- 
poiesis from (+/+) cells was markedly reduced in 50% me” 
chimeras (Figure 2). When the fraction of me” marrow was 
reduced to 20%, however, B cell production in the bone 
marrow was restored to normal. This finding establishes 
that PTPlC deficiency in cis does not affect differentiation 
of B cell precursors to the IgM+ stage, at least when the 
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cells carry productively rearranged immunoglobulin heavy 
and light chain transgenes. 
While PTPl C-deficient HEL-specific B cells developed 
normally within the bone marrow in the absence of HEL 
antigen, their accumulation in the periphery was markedly 
diminished by PTPlC deficiency in cis (Figure 3; Figure 
6). The latter could reflect either an antagonistic effect on 
B cell survival from deregulated antigen receptor signaling 
occurring in the absence of HEL antigen, or an indepen- 
dent effect of PTPlC deficiency on reception of B cell 
survival signals. Consistent with the possibility of deregu- 
lated immunoglobulin signaling, me” B cells in spleen, 
lymph node, and blood of 20% me” chimeras exhibited 
an unusual cell surface phenotype (IgM”, IgDhi, CRll 
CR2bmed, class II increased) equivalent to that of (+I+) 
B cells chronically exposed to soluble HEL autoantigen 
(Goodnow et al., 1968; Cooke et al., 1994). Precedent 
for the notion of elevated ligand-independent signaling in 
PTPl C-deficient cells is suggested by studies of erythroid 
cells from the spleen of adult me” mice, which exhibited 
erythropoietin-independent CFU-E formation (van Zant 
and Shultz, 1969). 
A role for PTPlC as a negative regulator of proximal 
signaling by immunoglobulin wasdirectlyestablished here 
by the larger and more rapid elevation of intracellular cal- 
cium in me” B cells than in (+I+) cells after binding a given 
amount of antigen. Based on this finding and the primary 
structure of the enzyme, it is likely that PTPl C is recruited 
to activated antigen receptors by binding to tyrosine- 
phosphorylated proteins through its two src homology 2 
domains, where it may inhibit signal transmission by de- 
phosphorylating one or more targets of the src-related and 
syk kinases that mediate early events in immunoglobulin 
signaling (Reth, 1992; Cambier et al., 1994; Gold and De- 
France, 1994). To confirm this speculation and illuminate 
where PTPl C acts within the signaling cascade, biochemi- 
cal studies of PTPlC function in B cells will be essential. 
Recruitment of PTPl C to activated membrane receptors 
has, in fact, recently been shown for c-Kit (Yi and Ihle, 
1993), an intrinsic receptor tyrosine kinase, and for the 
IL-3 receptor (Yi et al., 1993) which represents the large 
class of cytokine receptors that signal through recruited 
JAK kinases (Ihle et al., 1994). In the case of IL-3 receptor, 
PTPl C has also been suggested to act as a negative regu- 
lator as overexpression of the enzyme decreased IL3- 
induced proliferation and expression of an antisense con- 
struct weakly enhanced signaling (Vi et al., 1993). 
Collectively, these findings imply that the phosphatase 
acts on signaling by many different types of receptors that 
signal through tyrosine kinases. 
The effects of PTPl C deficiency on B cell development 
and selection provide direct evidence that tolerance 
thresholds are set by the strength of antigen receptor sig- 
naling. As outlined in Figure 8, establishment of such 
thresholds allows immunoglobulin affinity, antigen con- 
centration, and valency to be integrated to ensure that 
negative selection is neither too stringent nor too relaxed. 
Thus, under normal circumstances, only B cells that bind 
highly multivalent and widely distributed self-antigens, 
such as blood cell surface molecules or double-stranded 
A Normal immature Et cells 
Signal 
strength 
[Ag] , valency , affinity 
A 
PTPlC-de~~;immature 
[Ag] , valency , affinity 
Figure 8. Model Accounting for the Fate of 8 Cells with Wild-Type 
Levels or an Intracellular Deficiency of PTPIC 
See text for details. 
DNA, appear to be deleted in the bone marrow (Hartley 
et al., 1991; Nemazee et al., 1991; Okamoto et al., 1992; 
Gay et al., 1993), while other less strongly self-reactive 
specificities are preserved to form a diverse preimmune 
repertoire. When the dampening effects of PTPlC are ab- 
sent, however, B cells reactive with low valency self- 
antigens that would normally only be rendered anergic are 
also deleted and B cells that are negligibly self-reactive 
undergo many of the changes normally restricted to aner- 
gic self-reactive cells. Because many preimmune B cells 
appear weakly self-reactive in nontransgenic mice (Strie- 
bich et al., 1990; Kearneyet al., 1992), the lowered thresh- 
old for negative selection may explain the severe defi- 
ciency of IgD+ follicular B cells and poor antibody response 
following immunization characteristic of nontransgenic 
motheaten mice (Shultz and Green, 1976; Sidman et al., 
1978a; Davidson et al., 1979). 
While an increased stringency of negative selection pro- 
vides a possible explanation for B cell immunodeficiency 
in nontransgenic motheaten mice, the production of auto- 
antibodies in these mice is paradoxical. The predominant 
source of autoantibodies in me” mice is the pool of B-l -type 
B cells found particularly in the peritoneal cavity (Painter et 
al., 1968; Katsuri et al., 1990) some of which presumably 
must escape the exaggerated censoring occurring in the 
bone marrow. Precedent for this notion comes from a 
transgenic model of autoreactive B cells specific for an 
erythrocyte surface autoantigen, where B-l cells in the 
peritoneal cavity escape negative selection, apparently 
owing to lack of exposure to the antigen in this site (Oka- 
moto et al., 1992). In contrast with the erythrocyte antigen 
above, HEL-binding immunoglobulin-transgenic cells can- 
not escape censoring in this way, because both sHEL and 
mHEL are ubiquitous self-antigens. B-l cells are not defi- 
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cient in nontransgenic motheaten mice and antibody pro- 
duction by these cells is greatly increased (Sidman et al., 
1988) suggesting that regulation of B-l cells is disturbed 
when PTPlC is deficient in cis. This possibility is sup- 
ported by the finding that PTPlC-deficient B cells with the 
normally nonpermissive HEL-specific receptor assumed 
B-l characteristics selectively in the peritoneal cavity (Fig- 
ure 7). It will be important in future work to determine 
whether PTPlC deficiency affects regulation of B-l cells 
by altering immunoglobulin signaling or by effects on cy- 
tokine receptors, for example. 
The signaling threshold model for immunoglobulin re- 
ceptor selection established here parallels current models 
for selection of T cell antigen receptors. The need for a 
critical avidity of antigen recognition to trigger negative 
selection of self-reactive T cells has been clearly shown 
by elegant experiments in which the levels of CD8 and 
CD4 coreceptors or the potency of peptide antigen-MHC 
combinations have been varied systematically @obey et 
al., 1992; Ashton-Rickardt et al., 1993; Hogquist et al., 
1993; Killeen and Littman, 1993). It will be important in 
future work to determine whether PTPlC helps set selec- 
tion thresholds in T cells. The findings here also raise the 
possibility that inherited polymorphisms in PTPl C or com- 
parable regulatory molecules may vary the stringency of 
tolerance thresholds in outbred populations, and thus af- 
fect susceptibility to infection or autoimmunity. 
Experimental Procedures 
Motheaten Viable and Transgenic Mice 
Heterozygous C57BU6 me”/+ mice (Jackson Laboratories) were 
mated with C57BU6 MD4 immunoglobulin-transgenic mice and me”/+ 
heterozygous immunoglobulin-transgenic progeny were then mated 
with me” nontransgenic littermates. The C57BU6 HEL-transgenic mice 
used were the following: sHEL (ML5 line), which carries a transgene 
encoding hen egg lysozyme under the metallothionien promoter and 
contains HEL at 1 nM in serum (Goodnow et al., 1966); mHEL (KLK4 
line), which carries a transgene encoding HEL fused to class I trans- 
membrane and cytoplasmic regions under the class I promoter and 
expresses HEL on the surface of most cells (Hartley et al., 1991). 
Screening of me’ and Transgenlc Mice 
A polymerase chain reaction (PCR) assay was developed that specifi- 
cally identified carriers of the me”allele of PTPIC. The reverse primer 
(5”aagttgaggctttgccctt-3’) was designed with the 3’nucleotide comple- 
mentaryto the base substitution in theme%equence. To reduce further 
the efficiency of annealing to the wild-type template, a substitution of 
t for c was made at position 13 from the 5’ end. The forward primer 
(5’-aggctctgactacatcaat-3’) was specific for sequence 166 bp upstream 
of the mutation in the cDNA sequence. PCR was performed for 35 
cycles under the following conditions: 94% for 1 min, 59% for 1 
min, 72% for 1.5 min, using ear punch DNA and buffer as previously 
described (Chen and Evans, 1990). The product generated was ap- 
proximately 400 bp in size, 200 bp larger than predicted from the 
cDNA, indicating the presence of an intron of roughly 200 bp in this 
region of the gene (between nucleotides 994 and 1176 in the cDNA; 
numbering according to Matthewset al., 1992). me’homozygousprog- 
enywereidentifiable by IOdaysofage, owingtothemotheaten appear- 
ance of the skin. Screening for immunoglobulin or HEL transgenes 
was with transgene-specific oligonucleotides in the PCR as previously 
described (Hartley et al., 1993). 
Chlmeric Mice 
Lymphoid tissues were isolated as previously described (Goodnow et 
al., 1966). me” donors were sacrificed at 4-7 weeks of age, and bone 
marrow was mixed with wild-type bone marrow at the ratio stated in 
the results and 0.5-I x 107ceils were injected into the lateral tail vein 
of recipients that had been lethally irradiated with two doses of 450 
rads X-irradiation separated by 3 hr. The animals received antibiotics 
(Polymixin B, 110 mg/l and Neomcyin 1.1 g/l) in the drinking water for 
the whole 4-9 week reconstitution period until analysis. No differences 
were observed between mice that had been reconstituted for different 
periods. 
lmmunohlstochemistry 
Fragments of spleen were snap-frozen in liquid nitrogen at -60% until 
sectioned. Cryostat sections (6 urn) were cut, and the sections were 
fixed and stained as previously (Mason et al., 1992). IgM’was detected 
with biotinylated RS3.1 and avidinconjugated horseradish peroxidase 
(Amersham), and 8220 with the rat 682 monoclonal antibody (MAb) 
followed by goat anti-rat-conjugated alkaline phosphatase (Southern 
Biotechnical Associates). Enzyme reactions were developed with con- 
ventional substrates for peroxidase (diaminobenzidine/H20z) or for al- 
kaline phosphatase (fast red/Napthol AS-MX). Sections were counter- 
stained in haematoxylin and mounted in Crystal/Mount (Biomeda 
Corporation, Foster City, California). 
Flow Cytometric Analysis 
Three-color FACS analysis was performed on a FACScan with FACS 
desk software (Beckman Center Shared FACSfacility). Surface marker 
staining was performed as previously described (Goodnow et al., 1966; 
Mason et al., 1992). using the following MAbs: 8220, RA3-6B2-phy- 
coerythrin (PE; Caltag); IgM”, RS3.1-PE (Caltag); IgD”, AMS9.1-fluo- 
rescein isothiocyanate (FITC); igMb-FITC and IgDeFlTC (Phar- 
mingen); Ly5’, A261.7-FITC (a gifl of Dr. I. Weissman); CRi/CRP. 
7G6-biotin (Kinoshita et al., 1990; a gift of Dr. T. Kinoshita) and strep 
tavidin cychrome (Pharmingen); class II, anti-I-Ap-biotin (Pharmingen) 
and streptavidin cychrome. HEL binding was measured by incubating 
the cells with 200 rig/ml unlabeled HEL (Sigma) followed by biotinyl- 
ated anti-HEL MAb HyHEL9 and streptavidin cychrome. in some 
cases, Ly5’-FITC, IgMb-FITC, and IgDeFlTC were combined in the 
same stain to ensure that no B cells arising from residual recipient 
stem cells were gated in the Ly5’ (me” MD) window, especially where 
HEL binding was very low, as in soluble and membrane HEL recipients. 
Measurement of Serum Antl-HEL IgV and IgD’ 
96well plates (Flow Laboratories, Incorporated, McLean, Virginia) 
were coated with 1 pglml HEL (Sigma Chemical Company) in carbon- 
ate buffer (pH 9.2). The plates were blocked for 1 hr at 37% with IO 
mg/ml bovine serum albumin (Pentex, Kankakee, Illinois). Serum and 
standards diluted in 1 mg/ml bovine serum albumin in PBS were then 
applied to duplicate wells for 2 hr at 37%. Bound anti-HEL IgM* was 
developed with RSS.l-biotin and IgD” with AMSS.l-biotin followed 
by streptavidin-alkaline phosphatase (Sigma Chemical Compnay). Di- 
sodium p-nitrophenyl phosphate substrate (Sigma Chemical Com- 
pany) was then applied and plates read in a Molecular Devices (Menlo 
Park, California) enzyme-linked immunosorbent assay plate reader at 
405 nm. The concentrations of anti-HEL IgMO were determined relative 
to a standard curve of anti-HEL IgM’ from a transfectoma. 
Calcium Analysis 
Calcium analysis was conducted as previously described (Cooke et 
al., 1994). In brief, splenocytes or bone marrow cells were isolated at 
room temperature, washed, and resuspended at 10’ cells/ml in 5% 
bovine calf serum, RPMI, 10 mM HEPES. and loaded with the calcium 
indicator Indo-l AM (1 uM, final concentration; Molecular Probes, Incor- 
porated, Eugene, Oregon) for 30 min at 37%. Cells were washed and 
stained for Ly5” (A20-1.7-FITC), igMb (FITC), and igDL (FITC), and 
8220 (RA36B2-PE). In certain bone marrow analyses, CRi/CR2-bio- 
tin followed by streptavidin-PE (Caltag) was included to allow gating 
of mature B220”‘, CRl/CR2+ and immature B220b, CRl/CRP- cells. 
Indo-l-loaded and stained ceils were washed and suspended at 5 x 
lOBto 1 x 10’cells/mlandprewarmed to37”Cfor%5min immediately 
before analysis. Analysis was conducted at 37OC, unstimulated cells 
were collected for 45 s, antigen added at 1 min, and data collection 
continued for a total of 6 min with a flow rate of 200-400 electronically 
gated B220+ cells/s. Dectection of Indo-I, FITC, and PE fluorescence 
used a dual laser FACStar Plus flow cytometer (Becton-Dickinson). 
Conversion of Indo-l violet-blue fluorescence ratios to calcium levels 
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was determined as described (Rabinovitch et al., 1986; June and Rabin* 
vitch, 1990). 
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